Antibodies cited in Nature
Proteintech antibodies cited in Nature.
What matters to Proteintech is the success of its antibodies in the hands of scientists. Here’s just a small selection of recent high impact publications featuring Proteintech antibodies.
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Genome-embedded ribonucleotides are known as most abundant aberrant nucleotides in the genome of cycling cells. Zimmermann and colleagues suggest that manipulation of genomic ribonucleotide processing could be harnessed for therapeutic purposes and this strategy may expand the use of PARP inhibitors to some tumors that are proficient in homologous recombination. Michal Zimmermann et al. Nature volume 559, pages 285–289 (2018) Pubmed ID:29973717 Application: WB Species: human Cited Antibody: RNASEH2C Antibody
|
Single-cell analysis of early progenitor cells that build coronary arteriesInvestigation into cell fate conversion using single-cell RNA sequencing and mouse genetics of venous to arterial cells. Tianying Su et al. Nature volume 559, pages 356–362 (2018) Pubmed ID: 29973725 Application: IF Species: mouse Cited antibody: DACH1 Antibody
|